# GIST

Tumors pre and post imatinib treatement<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi

Mixed cancer types (including GIST) patients in vivo and later in pdx form, pre-treatment and post treatment<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212854<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE197763

Untreated GIST tumors and matched normal <br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112

## Single Cell

Sequening of intra and peri tumor GIST cancers - 4 samples
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162115

## Cell Line

Concurrent inhibition of CDK2 in GIST cell lines<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206257


# Melanoma

## Tumors

Pre and on Anti-PD1 Blockade<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE168204

Pre and post BRAFi treatment<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141484

Before and after MAPKi/PD-1 blockade treatment<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE158403

Before and after treatment with vaccine therapy<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE106128

Before and after treatment with RAF or RAF+MEK inhibitors<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77940

Before and after treatment debrafenib and trametinib<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61992

Uveal melanomas before and during treatment<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39717

Refactory Melanoma and NSCLC treated tumor biopsies (messy data)<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208858

Patient pre and post treatment<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE171484

Metastatic melanomas treated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE193157

Treated tumors<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122220

Pre and post treatment with BRAF or BRAF and MEK inhibitors<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196434

Uveal melanoma treated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE202687

Before treatment<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145996

Untreated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169203

Before treatment<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215868

Acral melanoma patients<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190113

Refactory melanomas treated with TIL-ACT<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE155389

Melanoma and other cancers pre and post treatments<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE159237

Patients treated with BRAF and or MEK inhibitors<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM6607055

Multi-type melanomas untreated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE174395

Patients untreated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160902

Patients untreated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221390

## Cell Lines

Treated and untreated with mitotane<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE186870

Treated and not treated with GSK3a/b inhibitor<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146415

Before and after treatments<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE167241

Treated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166617

Patient -derived cell lines untreated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208004

Uveal cell lines and primary tumors treated<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212219

Before and after IFNg exposure<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152755

## Single Cell Sequencing

Brain metastases pre and post treatment<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200218

HNSCC tumor tissues and blood of untreated patients with head and neck cancers<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169381

Patient-derived melanoma cell lines treated with vemurafenib<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE188469

# Breast Cancer

## Tumor

Pre and post treatment with mifepristone - 16 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212690

Pre and post treatment with combination epigenetic therapy - 46 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE179674

Pre and post treatment with sunitinib and docetaxel - 31 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58837

Pre and post radiation treatment - 62 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65505

Pre and during treatment with fulvestrant or anastrozole - 76 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71791

Untreated and treated with trastuzumab - 335 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47994

Various treatments in clinical trial - 455 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE223700

Chemotherapy treated - 119 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE106977

Tumors and matched metastatic tumors - 129 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE209998

Metastatic tumors and circulating tumor cells untreated - 87 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113890

Brain metastases untreated - 31 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161865

Pretreatment of early stage high risk - 105 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE173839

Pretreatment of early stage high risk - 150 samples<br>
ihttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE149322

Treated with durvalumab and bevacizumab - 6 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139050

Untreated tumors - 127 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE181574

Untreated tumors - 233 samples<br>
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180962

---

## üëã ü§† Howdy

To report a bug, request a feature, or leave a comment, just [submit an issue](https://github.com/KwatMDPhD/CancerData.pro/issues/new/choose).

Powered by https://github.com/KwatMDPhD/Kata.jl üåù
